Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

CORRECTION: Orgenesis Q2 EPS Loss Of $(0.23) Up From $(0.76) YoY, Sales $246.00K Up From $113.00K YoY

Author: Benzinga Newsdesk | August 09, 2024 04:35am
Orgenesis (NASDAQ:ORGS) reported quarterly losses of $(0.23) per share. This is a 69.74 percent increase over losses of $(0.76) per share from the same period last year. The company reported $246.00 thousand in sales this quarter. This is a 117.70 percent increase over sales of $113.00 thousand the same period last year.

Posted In: ORGS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist